Genome-Wide Association Study for Coronary Artery Calcification With Follow-Up in Myocardial InfarctionChristopher J. O’Donnell, Andreas Ziegler, Udo Hoffmann et al.|Circulation|2011Cited by 305
Interaction Between <i>PPARA</i> Genotype and β-Blocker Treatment Influences Clinical Outcomes Following Acute Coronary SyndromesSharon Cresci, John A. Spertus, Philip G. Jones et al.|Pharmacogenomics|2008Cited by 19
Interaction between the UCP2 -866 G>A polymorphism, diabetes, and β-blocker use among patients with acute coronary syndromesAmber L. Beitelshees, Daniel P. Kelly, Brian N. Finck et al.|Pharmacogenetics and Genomics|2010Cited by 17
Obesity–insulin targeted genes in the 3p26-25 region in human studies and LG/J and SM/J miceAldi T. Kraja, D. C. Rao, Heather A. Lawson et al.|Metabolism|2012Cited by 12
Interaction between PPARA genotype and β-blocker treatment influences clinical outcomes following acute coronary syndromesPhilip G. Jones, Adam Garsa, Daniel P. Kelly et al.|Unknown|2021Cited by 0